Our Board of Directors
Our board is comprised of years of leadership and professional experience; each is committed to our mission to raise awareness and funds in the fight against pediatric cancer.
NCI News Releases
13 August 2022
The latest cancer news from the U.S. government's principal agency for cancer research.-
Interferon treatment may reduce severity of COVID-19 in people with certain genetic factors
In patients with certain variations in the OAS1 gene, treatment for severe COVID-19 with interferons, a type of protein that can help the body’s immune system fight infections, decreased the viral load of SARS-CoV-2, a new study found.
-
COVID-19 was third leading cause of death in the United States in both 2020 and 2021
COVID-19 was the third leading cause of death in the United States between March 2020 and October 2021, according to an analysis of national death certificate data by researchers at the National Cancer Institute.
-
Four multinational, interdisciplinary teams selected to address major challenges in cancer
The Cancer Grand Challenges Program will award $100 million to four interdisciplinary teams from around the world to solve some of the toughest challenges in cancer research. Each team will receive $25 million over 5 years.
Feed not found.
